Trial intelligence / Profile preview

Magic Mouthwash + Sucralfate vs Benzydamine for Radiation-induced Mucositis

NCT00814359Phase 3Completed

Sponsor
Juravinski Hospital and Cancer Centre Foundation
Start
May 2009
Primary completion
Sep 2010
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 3, randomised, open-label trial of diphenhydramine, dexamethasone, nystatin oral suspension and sucralfate in oral mucositis (OM) (2 arms), sponsored by Juravinski Hospital and Cancer Centre Foundation. Primary endpoint: Change in Oral Mucositis Weekly Questionnaire - Head and Neck Cancer Score at 6 weeks. Started May 2009; status: completed.

02

Drugs

diphenhydraminedexamethasonenystatin oral suspensionsucralfate
03

Conditions

oral mucositis (OM)

Beyond the preview

Go deeper on NCT00814359.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00814359.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call